BackBristol-Myers Squibb Overview
Bristol-Myers Squibb Co.

Bristol-Myers Squibb Debt to Equity

Debt-to-Equity ratio (D/E) for BMY.

Get informed when a big investor buys or sells

+ Follow

Debt to Equity

2.22

Debt to Equity

2.22

Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.

Average Debt to Equity (Comparison Companies)

Loading

Debt to Equity History

Loading

Debt to Equity Comparison

Loading